[1]
M. Nogueira and T. Torres, “Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: Focus on Abrocitinib, Baricitinib, and Upadacitinib”, Dermatol Pract Concept, p. e2021145, Oct. 2021, doi: 10.5826/dpc.1104a145.